Sulfonamide and sulfamide substituted imidazoquinolines and methods for the treatment of periodontal disease using these and other immune response modifiers
申请人:3M Innovative Properties Company
公开号:US06825350B2
公开(公告)日:2004-11-30
The disclosure provides methods for the treatment and prevention of periodontal disease. In preferred embodiments, the invention provides for local treatment of periodontal tissues with a pharmaceutical composition including an immune response modifier (IRM) selected from the group of immune response modifiers comprising imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines and 1,2-bridged imidazoquinoline amines.
该披露提供了治疗和预防牙周病的方法。在优选实施例中,本发明提供了使用包括免疫应答调节剂(IRM)的药物组合物对牙周组织进行局部治疗的方法,所述IRM选自免疫应答调节剂组中的咪唑喹啉胺,咪唑吡啶胺,6,7-融合的环烷基咪唑吡啶胺,咪唑萘啉胺,噁唑喹啉胺,噻唑喹啉胺和1,2-桥联咪唑喹啉胺。